Home > National Drug Code (NDC) > Treatment Set TS344422

Treatment Set TS344422 - 49288-0835-3 - (Treatment Set TS344422)

Alphabetical Index


Drug Information of Treatment Set TS344422

Product NDC: 49288-0835
Proprietary Name: Treatment Set TS344422
Non Proprietary Name: Treatment Set TS344422
Active Ingredient(s): .002; .002; .002; 400; 400; 2000; .01    g/mL; g/mL; g/mL; [AU]/mL; [AU]/mL; [BAU]/mL; g/mL & nbsp;   Treatment Set TS344422
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Treatment Set TS344422

Product NDC: 49288-0835
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19861031

Package Information of Treatment Set TS344422

Package NDC: 49288-0835-3
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0835-3)

NDC Information of Treatment Set TS344422

NDC Code 49288-0835-3
Proprietary Name Treatment Set TS344422
Package Description 10 mL in 1 VIAL, MULTI-DOSE (49288-0835-3)
Product NDC 49288-0835
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Treatment Set TS344422
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19861031
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name ALTERNARIA ALTERNATA; CLADOSPORIUM HERBARUM; COCHLIOBOLUS SATIVUS; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; FELIS CATUS HAIR; PERIPLANETA AMERICANA
Strength Number .002; .002; .002; 400; 400; 2000; .01
Strength Unit g/mL; g/mL; g/mL; [AU]/mL; [AU]/mL; [BAU]/mL; g/mL
Pharmaceutical Classes Standardized Animal Hair Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Dander [Chemical/Ingredient],Allergens [Chemical/Ingredient],Salivary Proteins and Peptides [Chemical/Ingredient],Standardized Insect Protein Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Insect Protein Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Treatment Set TS344422


General Information